Comparative Bacteriostatic and Bactericidal Activities of Cefodizime against Borrelia burgdorferi Sensu Lato
AUTOR(ES)
Murgia, Rossella
FONTE
American Society for Microbiology
RESUMO
The MIC and MSC (minimum spirocheticidal concentration) and killing rate for Borrelia burgdorferi, the etiological agent of Lyme disease, were assessed for cefodizime in comparison with ceftriaxone, minocycline, azithromycin, roxithromycin, and ciprofloxacin. The range of cefodizime MICs was greater than those of azithromycin and roxithromycin but comparable to those of ceftriaxone and minocycline. The MSCs were 1 to 2 dilutions higher than the MICs of all of the tested compounds. The killing curves of cefodizime and ceftriaxone showed parallel courses. In conclusion, cefodizime exerted an activity comparable to that of ceftriaxone against B. burgdorferi.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=89610Documentos Relacionados
- Glycosphingolipid-binding protein of Borrelia burgdorferi sensu lato.
- First Isolation and Cultivation of Borrelia burgdorferi Sensu Lato from Missouri
- Analysis and comparison of plasmid profiles of Borrelia burgdorferi sensu lato strains.
- Molecular and Pathogenic Characterization of Borrelia burgdorferi Sensu Lato Isolates from Spain
- Molecular Typing of Borrelia burgdorferi Sensu Lato: Taxonomic, Epidemiological, and Clinical Implications